Technology
Health
Pharmaceutical
BiondVax Pharmaceuticals
$6.159876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$6.15
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.07 (1.13%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell BVXV and other stocks, options, ETFs, and crypto commission-free!
About BVXV
BiondVax Pharmaceuticals Ltd. American Depositary Shares, also called BiondVax Pharmaceuticals, is a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases. Read More It works on M-001, a synthetic peptide-based protein targeting both seasonal and pandemic strains of the influenza virus. The company was founded by Ron Babecoff and Rami Epstein on July 22, 2003 and is headquartered in Jerusalem, Israel.
Employees
21
Headquarters
Jerusalem, Jerusalem
Founded
2003
Market Cap
39.74M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
2.57K
High Today
$6.15
Low Today
$6.03
Open Price
$6.03
Volume
1.28K
52 Week High
$7.26
52 Week Low
$3.51
Collections
Technology
Health
Pharmaceutical
Medical
Biopharmaceutical
2015 IPO
Asia (Non-China)
Asia
Price Paid on Robinhood
4% Lower
Right Now
52 Week Low
$3.51
Average Price Paid
$6.39
52 Week High
$7.26
BVXV Earnings
-$0.05
-$0.03
-$0.02
$0.00
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 21, Pre-Market